Skip to content

Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate

C20H25N3O4 — CID 170692861

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate
SMILESCCOC(=O)c1cc2cn(C34CCC(C)(C3)OC4)nc2nc1OC1CCC1
InChIInChI=1S/C20H25N3O4/c1-3-25-18(24)15-9-13-10-23(20-8-7-19(2,11-20)26-12-20)22-16(13)21-17(15)27-14-5-4-6-14/h9-10,14H,3-8,11-12H2,1-2H3
InChIKeyAVKNBDOULJPKQX-UHFFFAOYSA-N
MW371.44 g/mol
LogP3.21
Rot. Bonds5

About Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate

Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate (PubChem CID 170692861) has the molecular formula C20H25N3O4 and a molecular weight of 371.44 g/mol. Its IUPAC name is ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate.

Molecular Properties

Compound NameEthyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate
PubChem CID170692861
Molecular FormulaC20H25N3O4
Molecular Weight371.44 g/mol
Exact Mass371.18
IUPAC Nameethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate
SMILESCCOC(=O)c1cc2cn(C34CCC(C)(C3)OC4)nc2nc1OC1CCC1
InChIInChI=1S/C20H25N3O4/c1-3-25-18(24)15-9-13-10-23(20-8-7-19(2,11-20)26-12-20)22-16(13)21-17(15)27-14-5-4-6-14/h9-10,14H,3-8,11-12H2,1-2H3
InChIKeyAVKNBDOULJPKQX-UHFFFAOYSA-N
XLogP3.21
TPSA75.47 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500371.44
LogP ≤ 53.21
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate?
The IUPAC name of Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate (CID 170692861) is ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate.
What is the SMILES notation for Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate?
The canonical SMILES for Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate is CCOC(=O)c1cc2cn(C34CCC(C)(C3)OC4)nc2nc1OC1CCC1.
What is the InChIKey of Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate?
The InChIKey is AVKNBDOULJPKQX-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H25N3O4/c1-3-25-18(24)15-9-13-10-23(20-8-7-19(2,11-20)26-12-20)22-16(13)21-17(15)27-14-5-4-6-14/h9-10,14H,3-8,11-12H2,1-2H3.
What are the key properties of Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate?
Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate has a molecular weight of 371.44 g/mol, XLogP of 3.21, 5 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for Ethyl 6-cyclobutyloxy-2-(1-methyl-2-oxabicyclo[2.2.1]heptan-4-yl)pyrazolo[3,4-b]pyridine-5-carboxylate is sourced from PubChem (CID 170692861), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.